Non-invasive Fat Reduction Sector | Savvy Players Spend on Brand Awareness to Up Sales

A report by Transparency Market Research, The Global Non-Invasive Fat Reduction Market is rising at a robust 15.9% CAGR from 2017 to 2025 which was valued at US$693.2 mn in 2016 will likely attain a value of US$2.50 bn by 2025, finds a report by Transparency Market Research. Catalyzing growth in the global non-invasive fat reduction market is the alarming rise in obesity worldwide due to consumption of calorie-laden fast foods and beverages and a sedentary lifestyle. In order to get rid of the excess body fat, which besides distorting the appearance is also harmful for health, people are increasingly opting for fat reduction and body contouring both through non-invasive and surgical procedures. In addition, increase in prevalence of diseases associated with obesity such as diabetes, growing preference of customers for aesthetic procedures, and their willingness to spend more on them has boosted the market growth of the global non-invasive fat reduction market.

Geographically, the key segments of the global non-invasive fat reduction market are North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America, among them, with a large proportion of obese population, currently holds a dominant share in the market vis-à-vis revenue. Presence of numerous new and established manufacturers in the region, who are coming up with advanced products quite frequently, along with the high spending capacity of people, is serving to drive the market. By registering a CAGR of 15.4%, the North America market is expected to hold on to its dominant share in the upcoming years as well.

Request to view Sample Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=18536

Some of the prominent participants in the global non-invasive fat reduction market are Fosun Pharmaceutical Co., Ltd., Cutera, Inc., Cynosure, Inc., ZELTIQ Aesthetics, Inc., and Syneron Medical Ltd. Of them, ZELTIQ Aesthetics, Syneron Medical Ltd., Fosun Pharmaceutical Co., Ltd, and Cynosure, Inc. have massive geographical outreach on account of multiple non-invasive fat reduction devices.